-The Hindu THIRUVANANTHAPURAM: Dengue, the world's most rapidly spreading mosquito-borne viral disease, is taking a far bigger human toll than was believed to be the case. As many as 390 million people across the globe could be falling victim to the virus each year, according to a multinational study published by Nature on Sunday. India emerges in the analysis as the country with the world's highest dengue burden, with about 34 per...
More »SEARCH RESULT
Total Matching Records found : 8943
Don't keep people on death row in limbo, CJI Altamas Kabir tells govt -Pradeep Thakur
-The Times of India Asking the government not to keep mercy petitions of death row convicts pending for a long time, Chief Justice of India Altamas Kabir on Sunday said execution of death penalty should not be delayed. He also faulted the government for not informing Parliament attack convict Afzal Guru's family members before he was hanged. "If a death penalty is to be awarded and it is there under the system,...
More »Most big patented drugs skip India -Rupali Mukherjee
-The Times of India Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. That's not all. The contribution of patented drugs in the Rs 72,000-crore pharma retail market is not even 1%, indicating that multinationals have been traditionally slow and have a poor track record in introducing...
More »Get Aadhaar to obtain PAN card now
-PTI The Unique Identification (UID) Aadhaar number will soon be a "valid" proof of identity and address to obtain a PAN card. A proposal for inclusion of Aadhaar in the existing list of valid proof of identification and proof of address for allotment of PAN was sent to the finance ministry by the Unique Identification Authority of India sometime back. The ministry has decided to notify rules in this regard. It is aimed...
More »Patent justice-Sakthivel Selvaraj
-The Hindu Drug patents are designed to create profits that enable more research on diseases affecting millions. But in practice, they have often generated super profits for big pharma companies while erecting access barriers for the poor. The Novartis case spotlights much that is wrong with the system. The rejection of the Novartis petition challenging one of the most progressive tenets of the Indian Patents Act (1970), as amended in 2005 by...
More »
